6 news items
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma
BMY
30 May 24
.
Breyanzi is broadly covered by commercial and government insurance programs in the U.S. Bristol Myers Squibb offers various programs
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
BMY
CVS
JNJ
29 May 24
for government pensions has been
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
ACON
AIRE
ATNI
25 Apr 24
. (NASDAQ:SPCB) climbed 19% to $0.2663. SuperCom received over $5 million in new orders from European Governments
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
BMY
25 Apr 24
."
Environmental, Social & Governance (ESG
Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
BMY
2 Apr 24
Environmental, Social, and Governance
- Prev
- 1
- Next